-
Symbol
-
MAZE on Nasdaq
-
Investment type
-
Equity / Common Stock - par value $0.001 per share
-
Latest Disclosed Shares Owned
-
608,948 shares
-
Security Ownership %
-
1.4%
James Tananbaum ownership in Maze Therapeutics, Inc. Common Stock - par value $0.001 per share (MAZE)
14 Nov 2025 - James Tananbaum has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 608,948 shares of Maze Therapeutics, Inc. Common Stock - par value $0.001 per share (MAZE).
This represents 1.4% ownership of the company.
In their previous filing dated 07 Feb 2025, Foresite Capital Fund IV, L.P. had reported owning 2,457,108 shares, indicating a decrease of +75%.
.